Silk Road Medical Statistics
Total Valuation
SILK has a market cap or net worth of $678.50 million. The enterprise value is $572.66 million.
| Market Cap | 678.50M |
| Enterprise Value | 572.66M |
Important Dates
The next confirmed earnings date is Tuesday, April 30, 2024, after market close.
| Earnings Date | Apr 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SILK has 39.17 million shares outstanding. The number of shares has increased by 8.47% in one year.
| Shares Outstanding | 39.17M |
| Shares Change (YoY) | +8.47% |
| Shares Change (QoQ) | +0.48% |
| Owned by Insiders (%) | 5.94% |
| Owned by Institutions (%) | 105.66% |
| Float | 38.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.83 |
| Forward PS | 3.40 |
| PB Ratio | 4.49 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.95, with a Debt / Equity ratio of 0.50.
| Current Ratio | 7.95 |
| Quick Ratio | 6.77 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.11 |
Financial Efficiency
Return on equity (ROE) is -36.10% and return on invested capital (ROIC) is -26.14%.
| Return on Equity (ROE) | -36.10% |
| Return on Assets (ROA) | -21.30% |
| Return on Capital (ROIC) | -26.14% |
| Revenue Per Employee | $373,700 |
| Profits Per Employee | -$117,601 |
| Employee Count | 474 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 2.04 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -60.59% in the last 52 weeks. The beta is 1.48, so SILK's price volatility has been higher than the market average.
| Beta (1Y) | 1.48 |
| 52-Week Price Change | -60.59% |
| 50-Day Moving Average | 17.35 |
| 200-Day Moving Average | 15.44 |
| Relative Strength Index (RSI) | 47.91 |
| Average Volume (30 Days) | 770,274 |
Short Selling Information
The latest short interest is 4.09 million, so 10.44% of the outstanding shares have been sold short.
| Short Interest | 4.09M |
| Short Previous Month | 3.72M |
| Short % of Shares Out | 10.44% |
| Short % of Float | 10.68% |
| Short Ratio (days to cover) | 4.25 |
Income Statement
In the last 12 months, SILK had revenue of $177.13 million and -$55.74 million in losses. Loss per share was -$1.44.
| Revenue | 177.13M |
| Gross Profit | 127.09M |
| Operating Income | -59.27M |
| Pretax Income | -55.74M |
| Net Income | -55.74M |
| EBITDA | -45.08M |
| EBIT | -48.87M |
| Loss Per Share | -$1.44 |
Balance Sheet
The company has $181.47 million in cash and $75.63 million in debt, giving a net cash position of $105.85 million or $2.70 per share.
| Cash & Cash Equivalents | 181.47M |
| Total Debt | 75.63M |
| Net Cash | 105.85M |
| Net Cash Per Share | $2.70 |
| Equity / Book Value | 151.15M |
| Book Value Per Share | 3.86 |
| Working Capital | 210.55M |
Cash Flow
In the last 12 months, operating cash flow was -$32.01 million and capital expenditures -$1.51 million, giving a free cash flow of -$33.52 million.
| Operating Cash Flow | -32.01M |
| Capital Expenditures | -1.51M |
| Free Cash Flow | -33.52M |
| FCF Per Share | -$0.86 |
Margins
Gross margin is 71.75%, with operating and profit margins of -33.46% and -31.47%.
| Gross Margin | 71.75% |
| Operating Margin | -33.46% |
| Pretax Margin | -31.47% |
| Profit Margin | -31.47% |
| EBITDA Margin | -25.45% |
| EBIT Margin | -27.59% |
| FCF Margin | -18.92% |
Dividends & Yields
SILK does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.47% |
| Shareholder Yield | -8.47% |
| Earnings Yield | -8.22% |
| FCF Yield | -4.94% |
Analyst Forecast
The average price target for SILK is $23.90, which is 37.99% higher than the current price. The consensus rating is "Buy".
| Price Target | $23.90 |
| Price Target Difference | 37.99% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 13.20% |
| EPS Growth Forecast (5Y) | -4.38% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SILK has an Altman Z-Score of 2.47 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.47 |
| Piotroski F-Score | 1 |